About Innovassynth Technologies
Innovassynth Technologies is a company based in Mumbai (India) founded in 1964. The company has 293 employees as of April 06, 2025. Innovassynth Technologies offers products and services including Nucleosides, Specialty Chemicals, and Contract Manufacturing. Innovassynth Technologies operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
- Employees 293 as on 06 Apr, 2025
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Innovassynth Technologies (India ) Limited
- Date of Incorporation 04 Dec, 2001
- Jurisdiction Khopoli, Maharashtra, India
-
Annual Revenue
$18.85 M (USD)-20.8as on Mar 31, 2024
-
Net Profit
-$54.66 K (USD)83.84as on Mar 31, 2024
-
EBITDA
$1.31 M (USD)212.68as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
293
as on Apr 06, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Innovassynth Technologies
Innovassynth Technologies offers a comprehensive portfolio of products and services, including Nucleosides, Specialty Chemicals, and Contract Manufacturing.
Products for nucleic acid chemistry and manufacturing services
Custom development of organometallics and polymers additives
Full-scale manufacturing for pharma and chemical intermediates
People of Innovassynth Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Innovassynth Technologies
Investments & Acquisitions by Innovassynth Technologies
Financial Statements - Innovassynth Technologies
Innovassynth Technologies Comparisons
Competitors of Innovassynth Technologies
Innovassynth Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
Latest news on Innovassynth Technologies
Frequently Asked Questions about Innovassynth Technologies
Innovassynth Technologies was founded in 1964.
Innovassynth Technologies is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Apr 06, 2025, the latest employee count at Innovassynth Technologies is 293.
Annual revenue of Innovassynth Technologies is $18.85M as on Mar 31, 2024.
Innovassynth Technologies (formerly known as Chemicals Division of Indian Organic Chemicals) is engaged in contract research, custom synthesis and contract manufacturing. Business segments include Pharma intermediates, protected nucleosides and amidites, protected amino acids for peptide synthesis, fine chemicals and nutraceuticals. It has also set up a cGMP pilot plant facility where 10-15 Kg batch size production is possible and is going for US FDA approval in near future. The company claims to have more than 45 customers in USA, Europe and Japan for its contract manufacturing business.
Innovassynth Technologies's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Innovassynth Technologies offers Nucleosides, Specialty Chemicals, and Contract Manufacturing.